المؤلفون: Grisham, RN, Slomovitz, BM, Andrews, N, Banerjee, S, Brown, J, Carey, MS, Chui, H, Coleman, RL, Fader, AN, Gaillard, S, Gourley, C, Sood, AK, Monk, BJ, Moore, KN, Ray-Coquard, I, Shih, I-M, Westin, SN, Wong, K-K, Gershenson, DM

المساهمون: Banerjee, Susana

مصطلحات موضوعية: Cystadenocarcinoma, Serous, Ovarian Cancer, Pathology, Humans, Female, Consensus, Quality of Life, Peritoneal Neoplasms, Carcinoma, Ovarian Epithelial, Papillary, Ovarian Neoplasms

جغرافية الموضوع: England

وصف الملف: Electronic; 1344; application/pdf

Relation: ijgc-2023-004610; International Journal of Gynecological Cancer, 2023, 33 (9), pp. 1331 - 1344; https://repository.icr.ac.uk/handle/internal/6081

الاتاحة: https://repository.icr.ac.uk/handle/internal/6081
https://doi.org/10.1136/ijgc-2023-004610

المؤلفون: Cremona, M, Vandenberg, CJ, Farrelly, AM, Madden, SF, Morgan, C, Kalachand, R, McAlpine, JN, Toomey, S, Huntsman, DG, Grogan, L, Breathnach, O, Morris, P, Carey, MS, Scott, CL, Hennessy, BT

Relation: pii: 10.1038/s41416-022-01823-5; Cremona, M., Vandenberg, C. J., Farrelly, A. M., Madden, S. F., Morgan, C., Kalachand, R., McAlpine, J. N., Toomey, S., Huntsman, D. G., Grogan, L., Breathnach, O., Morris, P., Carey, M. S., Scott, C. L. & Hennessy, B. T. (2022). BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors. BRITISH JOURNAL OF CANCER, 127 (3), pp.488-499. https://doi.org/10.1038/s41416-022-01823-5.; http://hdl.handle.net/11343/309090

الاتاحة: http://hdl.handle.net/11343/309090

المؤلفون: Cheasley, D, Fernandez, ML, Kobel, M, Kim, H, Dawson, A, Hoenisch, J, Bittner, M, Chiu, DS, Talhouk, A, Gilks, CB, Jayawardana, MW, Pishas, K, Mes-Masson, A-M, Provencher, D, Nigam, A, Hacker, NF, Gorringe, KL, Campbell, IG, Carey, MS

Relation: pii: 10.1038/s41698-022-00288-2; Cheasley, D., Fernandez, M. L., Kobel, M., Kim, H., Dawson, A., Hoenisch, J., Bittner, M., Chiu, D. S., Talhouk, A., Gilks, C. B., Jayawardana, M. W., Pishas, K., Mes-Masson, A. -M., Provencher, D., Nigam, A., Hacker, N. F., Gorringe, K. L., Campbell, I. G. & Carey, M. S. (2022). Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression. NPJ PRECISION ONCOLOGY, 6 (1), https://doi.org/10.1038/s41698-022-00288-2.; http://hdl.handle.net/11343/316698

الاتاحة: http://hdl.handle.net/11343/316698

المؤلفون: Kalachand RD, Stordal B, Madden S, Chandler B, Cunningham J, Goode EL, Ruscito I, Braicu EI, Sehouli J, Ignatov A, Yu H, Katsaros D, Mills GB, Lu KH, Carey MS, Timms KM, Kupryjanczyk J, Rzepecka IK, Podgorska A, McAlpine JN, Swisher EM, Bernards SS, O'Riain C, O'Toole S, O'Leary JJ, Bowtell DD, Thomas DM, Prieske K, Joosse SA, Woelber L, Chaudhry P, Häfner N, Runnebaum IB, Hennessy BT.

المساهمون: Kalachand, Rd, Stordal, B, Madden, S, Chandler, B, Cunningham, J, Goode, El, Ruscito, I, Braicu, Ei, Sehouli, J, Ignatov, A, Yu, H, Katsaros, D, Mills, Gb, Lu, Kh, Carey, M, Timms, Km, Kupryjanczyk, J, Rzepecka, Ik, Podgorska, A, McAlpine, Jn, Swisher, Em, Bernards, S, O'Riain, C, O'Toole, S, O'Leary, Jj, Bowtell, Dd, Thomas, Dm, Prieske, K, Joosse, Sa, Woelber, L, Chaudhry, P, Häfner, N, Runnebaum, Ib, Hennessy, Bt.

مصطلحات موضوعية: ovarian cancer, BRCA, methylation, mutation: promoter

Relation: info:eu-repo/semantics/altIdentifier/pmid/32413141; info:eu-repo/semantics/altIdentifier/wos/WOS:000606177900005; firstpage:1; lastpage:14; numberofpages:14; journal:JOURNAL OF THE NATIONAL CANCER INSTITUTE; http://hdl.handle.net/11573/1403102; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85089864435

الاتاحة: http://hdl.handle.net/11573/1403102
https://doi.org/10.1093/jnci/djaa070

المؤلفون: Oza, AM, Cook, AD, Pfisterer, J, Embleton, A, Ledermann, JA, Pujade-Lauraine, E, Kristensen, G, Carey, MS, Beale, P, Cervantes, A, Park-Simon, TW, Rustin, G, Joly, F, Mirza, MR, Plante, M, Quinn, M, Poveda, A, Jayson, GC, Stark, D, Swart, AM, Farrelly, L, Kaplan, R, Parmar, MK, Perren, TJ, ICON7, trial investigators

المصدر: Lancet Oncology , 16 (8) pp. 928-936. (2015)

وصف الملف: text

Relation: https://discovery.ucl.ac.uk/id/eprint/1469584/6/Oza_Standard%20chemotherapy%20with%20or%20without%20bevacizumab%20for%20women%20with.pdf; https://discovery.ucl.ac.uk/id/eprint/1469584/

الاتاحة: https://discovery.ucl.ac.uk/id/eprint/1469584/6/Oza_Standard%20chemotherapy%20with%20or%20without%20bevacizumab%20for%20women%20with.pdf
https://discovery.ucl.ac.uk/id/eprint/1469584/

المؤلفون: Cheasley, D, Nigam, A, Zethoven, M, Hunter, S, Etemadmoghadam, D, Semple, T, Allan, P, Carey, MS, Fernandez, ML, Dawson, A, Kobel, M, Huntsman, DG, Le Page, C, Mes-Masson, A-M, Provencher, D, Hacker, N, Gao, Y, Bowtell, D, deFazio, A, Gorringe, KL, Campbell, IG

مصطلحات الفهرس: Journal Article

URL: http://hdl.handle.net/11343/276541
NHMRC/400281
NHMRC/1041975
NHMRC/400413
NHMRC/1092856

المؤلفون: Kalachand, RD, Stordal, B, Madden, S, Chandler, B, Cunningham, J, Goode, EL, Ruscito, I, Braicu, E, Sehouli, J, Ignatov, A, Yu, H, Katsaros, D, Mills, GB, Lu, KH, Carey, MS, Timms, KM, Kupryjanczyk, J, Rzepecka, IK, Podgorska, A, McAlpine, JN, Swisher, EM, Bernards, SS, O'Riain, C, O'Toole, S, O'Leary, JJ, Bowtell, DD, Thomas, DM, Prieske, K, Joosse, SA, Woelber, L, Chaudhry, P, Hafner, N, Runnebaum, IB, Hennessy, BT

Relation: pii: 5837681; Kalachand, R. D., Stordal, B., Madden, S., Chandler, B., Cunningham, J., Goode, E. L., Ruscito, I., Braicu, E., Sehouli, J., Ignatov, A., Yu, H., Katsaros, D., Mills, G. B., Lu, K. H., Carey, M. S., Timms, K. M., Kupryjanczyk, J., Rzepecka, I. K., Podgorska, A. ,. Hennessy, B. T. (2020). BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 112 (12), pp.1190-1203. https://doi.org/10.1093/jnci/djaa070.; http://hdl.handle.net/11343/281485

الاتاحة: http://hdl.handle.net/11343/281485

المؤلفون: Cheasley, D, Nigam, A, Zethoven, M, Hunter, S, Etemadmoghadam, D, Semple, T, Allan, P, Carey, MS, Fernandez, ML, Dawson, A, Kobel, M, Huntsman, DG, Le Page, C, Mes-Masson, A-M, Provencher, D, Hacker, N, Gao, Y, Bowtell, D, deFazio, A, Gorringe, KL, Campbell, IG

Relation: NHMRC/400281; NHMRC/1041975; NHMRC/400413; NHMRC/1092856; Cheasley, D., Nigam, A., Zethoven, M., Hunter, S., Etemadmoghadam, D., Semple, T., Allan, P., Carey, M. S., Fernandez, M. L., Dawson, A., Kobel, M., Huntsman, D. G., Le Page, C., Mes-Masson, A. -M., Provencher, D., Hacker, N., Gao, Y., Bowtell, D., deFazio, A. ,. Campbell, I. G. (2020). Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities. JOURNAL OF PATHOLOGY, 253 (1), pp.41-54. https://doi.org/10.1002/path.5545.; http://hdl.handle.net/11343/276541

الاتاحة: http://hdl.handle.net/11343/276541

المؤلفون: Gardner, R, Davies, T, Carey, MS

Relation: https://ora.ox.ac.uk/objects/uuid:4d0a063b-0782-4bfb-9442-1bc6a2a35373; https://doi.org/10.1016/0143-4004(88)90048-3

الاتاحة: https://doi.org/10.1016/0143-4004(88)90048-3
https://ora.ox.ac.uk/objects/uuid:4d0a063b-0782-4bfb-9442-1bc6a2a35373

المؤلفون: Ledermann, JA, Marth, C, Carey, MS, Birrer, M, Bowtell, DDL, Kaye, S, McNeish, I, Oza, A, Scambia, G, Rustin, G, Stehman, FB, Gershenson, D, Thomas, Giju, Berns, Els, Casado, A, Ottevanger, N, Hilpert, F, Kim, BG, Okamoto, A, Bacon, M, Kitchener, H, Stuart, GCE

المصدر: Ledermann , JA , Marth , C , Carey , MS , Birrer , M , Bowtell , DDL , Kaye , S , McNeish , I , Oza , A , Scambia , G , Rustin , G , Stehman , FB , Gershenson , D , Thomas , G , Berns , E , Casado , A , Ottevanger , N , Hilpert , F , Kim , BG , Okamoto , A , Bacon , M , Kitchener , H & Stuart , GCE 2011 , ' Role of Molecular Agents and Targeted Therapy in Clinical ....

مصطلحات موضوعية: /dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM038601, name=EMC MM-03-86-01, /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, name=SDG 3 - Good Health and Well-being

الاتاحة: https://pure.eur.nl/en/publications/6400edb9-32d7-4dce-82ff-31d3b4275545
https://doi.org/10.1097/IGC.0b013e31821b2669

المؤلفون: Perren, TJ, Swart, AM, Pfisterer, J, Ledermann, JA, Pujade-Lauraine, E, Kristensen, G, Carey, MS, Beale, P, Cervantes, A, Kurzeder, C, du Bois, A, Sehouli, J, Kimmig, R, Stähle, A, Collinson, F, Essapen, S, Gourley, C, Lortholary, A, Selle, F, Mirza, MR, Leminen, A, Plante, M, Stark, D, Qian, W, Parmar, MKB, Oza, AM

وصف الملف: text

Relation: https://eprints.whiterose.ac.uk/136581/1/A%20Phase%203%20Trial%20of%20Bevacizumab%20in%20Ovarian%20Cancer.pdf; Perren, TJ orcid.org/0000-0001-8472-8856 , Swart, AM, Pfisterer, J et al. (23 more authors) (2011) A Phase 3 Trial of Bevacizumab in Ovarian Cancer. New England Journal of Medicine, 365. pp. 2484-2496. ISSN 0028-4793

الاتاحة: https://eprints.whiterose.ac.uk/136581/
https://eprints.whiterose.ac.uk/136581/1/A%20Phase%203%20Trial%20of%20Bevacizumab%20in%20Ovarian%20Cancer.pdf